Low-dose rivaroxaban for acute ischemic stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a low-dose blood thinner called rivaroxaban, given for 90 days after a recent ischemic stroke, to see if it reduces the risk of another stroke or heart problems. It may be an option for people who are already receiving standard stroke care and are not on full-dose blood thinners.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had an ischemic stroke within the last 14 days.
- You are at least 18 years old.
- You are getting usual care for your stroke and, if you had a clot-dissolving drug, it was at least 24 hours ago.
- You are not already taking a full-dose blood thinner for another condition.
- You do not have severe kidney or liver failure.
- You have not had a bleeding stroke in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a combination of two blood-thinning medications (clopidogrel and rivaroxaban) is better than standard treatment (aspirin alone or aspirin plus clopidogrel) for preventing another stroke in people who have a narrowed artery inside the brain. It aims to reduce the risk of future strokes while managing bleeding risks.
This trial tests whether giving a clot-dissolving medicine (alteplase or tenecteplase) is safe and effective for people who have had a stroke and are taking a blood thinner (DOAC) like apixaban or rivaroxaban. It aims to see if this treatment can still be given within a few hours of the stroke.
This study tests whether a lower dose of the blood thinner rivaroxaban is safe for people with kidney failure on dialysis who do not already need blood thinners. The goal is to find a way to prevent blood clots and strokes with less risk of bleeding.
This trial tests two doses of rivaroxaban (15mg and 20mg) to see how well they prevent strokes in people with non-valvular atrial fibrillation, a type of irregular heartbeat not caused by a heart valve problem. It may be an option if you need blood thinners to lower your stroke risk.
This study tests two different blood-thinning medicines to see which is better at preventing another stroke in people who recently had a stroke with no clear cause. The goal is to find a treatment that works well and is safe for you.
This trial tests if a full dose of rivaroxaban (a blood thinner) works better than a lower preventive dose for treating a superficial vein clot in the leg. It aims to find the safest and most effective way to stop the clot from getting worse or causing a more serious clot.
Hear when a new Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.